{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T07:04:13Z","timestamp":1649142253473},"reference-count":10,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":2912,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1016\/j.jacc.2005.04.058","type":"journal-article","created":{"date-parts":[[2005,8,10]],"date-time":"2005-08-10T14:08:39Z","timestamp":1123682919000},"page":"752-755","source":"Crossref","is-referenced-by-count":9,"title":["Secondary Stroke Prevention With Antiplatelet Therapy With Emphasis on the Cardiac Patient"],"prefix":"10.1016","volume":"46","author":[{"suffix":"Jr","given":"James M.","family":"Gebel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2005.04.058_bib1","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2005.04.058_bib2","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2005.04.058_bib3","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(04)16721-4","article-title":"Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic or transient ischaemic attack in high-risk patients (MATCH)","volume":"364","author":"Diener","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2005.04.058_bib4","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/ana.410290605","article-title":"The European Stroke Prevention Study (ESPS)","volume":"29","author":"Sivenius","year":"1991","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jacc.2005.04.058_bib5","doi-asserted-by":"crossref","first-page":"909","DOI":"10.2165\/00003088-200342100-00003","article-title":"Clinical pharmacokinetics of antiplatelet agents used in the secondary prevention of stroke","volume":"42","author":"Lenz","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jacc.2005.04.058_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(96)00308-5","article-title":"European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke","volume":"143","author":"Diener","year":"1996","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jacc.2005.04.058_bib7","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1161\/hs0402.105246","article-title":"Occurrence of secondary ischemic events among persons with atherosclerotic vascular disease","volume":"33","author":"Vickrey","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2005.04.058_bib8","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJM198908243210804","article-title":"A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients","volume":"321","author":"Hass","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2005.04.058_bib9","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/S0140-6736(89)92327-1","article-title":"The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke","volume":"1","author":"Gent","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2005.04.058_bib10","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1001\/jama.289.22.2947","article-title":"Aspirin and ticlopidine for prevention of recurrent stroke in black patients","volume":"289","author":"Gorelick","year":"2003","journal-title":"JAMA"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109705012799?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109705012799?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T20:58:36Z","timestamp":1548277116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109705012799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S0735109705012799"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2005.04.058","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}